Aptevo Therapeutics Inc

United States · 57 Employees
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what's next in biotechnology.

概述

国家 United States
成立时间 2016
总部 2401 4th Avenue, Suite 1050, Seattle, WA 98101, US
电话号码 +1 206-838-0500
网站 http://www.aptevotherapeutics.com
LinkedIn http://www.linkedin.com/company/aptevo-therapeutics-inc
Twitter https://twitter.com/aptevo
Facebook
员工数 57
行业 research,
简介 Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what's next in biotechnology.

技术

Amazon AWS

Hosting

Apache

Load Balancers

Google Analytics

Analytics and Tracking

Mobile Friendly

Other

Outlook

Email Providers

Sendgrid

Email Delivery

WordPress.org

CMS

常见问题

Aptevo Therapeutics Inc 在哪里?

Aptevo Therapeutics Inc 的总部位于 2401 4th Avenue, Suite 1050, Seattle, WA 98101, US

Aptevo Therapeutics Inc 的电话号码是多少?

Aptevo Therapeutics Inc 的电话号码是 +1 206-838-0500

Aptevo Therapeutics Inc 的官方网站是什么?

Aptevo Therapeutics Inc 的公司官方网站是 http://www.aptevotherapeutics.com

Aptevo Therapeutics Inc 是做什么的?

Aptevo Therapeutics Inc 的业务有哪些?

Aptevo Therapeutics Inc 的年收入是多少?

Aptevo Therapeutics Inc 的收入是 3114000美元

Aptevo Therapeutics Inc 有多少员工?

Aptevo Therapeutics Inc 有 57 名员工

Aptevo Therapeutics Inc 属于哪个行业?

Aptevo Therapeutics Inc 从事以下行业: research

Aptevo Therapeutics Inc 使用什么技术?

Aptevo Therapeutics Inc 使用的一些流行技术包括: Amazon AWS,Apache,Google Analytics,Mobile Friendly,Outlook,Sendgrid,WordPress.org

如何联系 Aptevo Therapeutics Inc?

Aptevo Therapeutics Inc 联系信息: 电话号码:+1 206-838-0500, 网站:http://www.aptevotherapeutics.com, 邮箱:bon***@***.com

Aptevo Therapeutics Inc 的社交媒体链接是什么?

Aptevo Therapeutics Inc 领英:http://www.linkedin.com/company/aptevo-therapeutics-inc,fackbook:,twitte:https://twitter.com/aptevo

Aptevo Therapeutics Inc 是一家上市公司吗?

是的,Aptevo Therapeutics Inc是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:APVO

Aptevo Therapeutics Inc 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Aptevo Therapeutics Inc?

Aptevo Therapeutics Inc 有 0 家投资者,包括 。

管理层

Lynn Bonham

Senior Director Translational Pharmacology

Will Benjamin

Director FP&A / IT

Dave Jablonski

Manager Analytical Development

员工

Sally Gould

Regulatory Affairs Consultant

Gary Jurgensen

Associate Scientist II

Megan V

Assistant Scientist II

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google